Physician profile

Henry Goodwin

Urology · Evans, GA

NPI 1265467286

$9,743.76

in general payments reported to CMS, 2019-2025

49 companies · $1,307 in 2025

The $1,307 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,385.00
Education$53.53

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Myriad Genetic Laboratories, INC. $849.17 2023 Prolaris
Axonics, INC. $747.26 2021-2024 Axonics
Astellas Pharma US INC $698.44 2019-2025 Xtandi
Janssen Biotech, INC. $681.78 2019-2025 Erleada, Akeega
Bayer Healthcare Pharmaceuticals INC. $536.88 2020-2025
Procept Biorobotics Corporation $508.98 2023-2025 Aquabeam System, Aquabeam Robotic System
Sumitomo Pharma America, INC. $463.16 2023-2025 Orgovyx, Gemtesa
Teleflex LLC $447.12 2023-2024 Urolift
Accord Healthcare, INC. $427.94 2022-2025
Abbvie INC. $426.27 2019-2025
Coloplast Corp $393.84 2019-2025
Pfizer INC. $367.01 2019-2025
Dendreon Pharmaceuticals LLC $307.02 2019-2024 Provenge
Endo Pharmaceuticals INC. $302.75 2019-2024 Xiaflex, Aveed
Medtronic, INC. $286.26 2024-2025 Interstim
Show all 49 companies
CompanyGeneral paymentsYearsTop products
Ferring Pharmaceuticals INC. $251.67 2024 Adstiladrin
Boston Scientific Corporation $194.52 2019-2025 Axonics, Spaceoar System
Merck Sharp & Dohme LLC $181.52 2020-2025 Keytruda, Lynparza, Bridion
Myovant Sciences INC. $178.35 2021-2022
Allergan, INC. $151.26 2019-2021
Alnylam Pharmaceuticals INC. $109.79 2024 Oxlumo
Neotract INC. $109.13 2019
Cook Medical LLC $96.36 2020
Verity Pharmaceuticals INC. $89.15 2024-2025 Trelstar
Urogen Pharma, INC. $78.83 2022-2025 Jelmyto
Astrazeneca Pharmaceuticals LP $69.53 2022-2023 Lynparza
Travere Therapeutics, INC. $62.00 2019-2022
Laborie Medical Technologies Corp. $60.87 2023-2024 Optilume Bph Drug Coated Balloon Catheter
Caldera Medical, INC $55.62 2023 Desara
Blue Earth Diagnostics $50.94 2019-2024
Immunitybio, INC. $49.57 2025
Progenics Pharmaceuticals, INC. $48.82 2023-2025 Pylarify
Novartis Pharmaceuticals Corporation $46.93 2019-2023
Clarus Therapeutics INC. $43.50 2021
Therapeuticsmd, INC. $41.49 2019
Agiliti Surgical, INC. $40.70 2024 Koelis Trinity Fusion Biopsy System, Sonablate Hifu
C. R. Bard, INC. & Subsidiaries $40.47 2022-2023 Bard Urinary Drainage Bag
Antares Pharma, INC. $39.28 2022-2023 Tlando, Nocdurna, Xyosted
Endo USA, INC. $31.36 2024 Xiaflex
Innovation Technologies INC $25.44 2025 Irrisept
Tolmar, INC. $21.68 2023
Ambu INC. $19.62 2020-2022
Ethicon US, LLC $18.37 2024 Harmonic, Echelon Flex, Echelon Endopath
180 Medical, INC. $17.36 2025
Rochester Medical Corporation $16.93 2019
Foundation Medicine, INC. $16.57 2022
Smith+Nephew, INC. $15.10 2022
Cardinal Health 414 LLC $13.76 2023
Abbott Laboratories $13.39 2024 Proclaim

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Henry Goodwin

$9,743.76

in general payments reported 2019-2025

Years
2019-2025
Top company
Myriad Genetic Laboratories, INC.
Context
The $1,307 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/239386/henry-goodwin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.